63882-42-8

Basic information

• Product Name: 2-(2-methylphenyl)cyclohexanone
• CAS NO: 63882-42-8
• Molecular Formula: C₁₃H₁₆O
• Molecular Weight: 188.2655
• Mol File: 63882-42-8.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 314.5°C at 760 mmHg
• Flash Point: 133.7°C
• Density: 1.026g/cm³
• Vapor Pressure: 0.000463mmHg at 25°C
• Refractive Index: 1.534
• CAS DataBase Reference: 2-(2-methylphenyl)cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-methylphenyl)cyclohexanone(63882-42-8)
• EPA Substance Registry System: 2-(2-methylphenyl)cyclohexanone(63882-42-8)

Safety Data

• Hazardous Substances Data: 63882-42-8(Hazardous Substances Data)

Upstream product

• 932-31-0 ortho-tolylmagnesium bromide 
• 822-87-7 2-Chlorocyclohexanone 
• 83324-21-4 2-o-tolyl-cyclohexanone-syn-phenylhydrazone 
• 523-25-1 (+/-)-trans-2-(2-methylphenyl)cyclohexan-1-ol 
• 523-25-1 2-(o-tolyl)cyclohexan-1-ol 
• 6651-36-1 1-(Trimethylsilyloxy)cyclohexene 
• 95-49-8 2-methylchlorobenzene 
• 95-46-5 2-methylphenyl bromide 
• 286-20-4 cyclohexane-1,2-epoxide 
• 5300-19-6 1-phenylazocyclohex-1-ene 
• 22618-51-5 2'-methyl-2,3,4,5-tetrahydro-1,1'-biphenyl 
• 108-94-1 cyclohexanone 
• 930-68-7 cyclohexenone 
• 615-37-2 ortho-methylphenyl iodide 

Downstream Products

• 21481-86-7 (-)-cis-2-(o-Tolyl)-cyclohexanol <(-)-1(a)-Hydroxy-2(e)-o-tolyl-cyclohexan> 
• 523-25-1 (+/-)-cis-2-(o-Tolyl)-cyclohexanol <(+/-)-1(a)-Hydroxy-2(e)-o-tolyl-cyclohexan> 
• 1265904-96-8 2-(4-methylbiphenyl-3-yl)cyclohexanone 
• 1309458-29-4 trimethyl(6-o-tolylcyclohex-1-enyloxy)silane 
• 1309458-22-7 1-(cyclohexa-2,4-dienyl)-2-methylbenzene 
• 97023-15-9 6-o-tolylcyclohex-2-enol 
• 91909-22-7 6-o-tolylcyclohex-2-enone 
• 1316848-60-8 2-(2-methylphenyl)-1-(trimethylsiloxy)cyclohex-1-ene 

Relevant articles and documents

NMDA receptor antagonist and use thereof

The present invention relates to an NMDA receptor antagonist and use thereof. The NMDA receptor antagonist is a compound as shown in the formula I, and pharmaceutically acceptable salts, enantiomers, diastereoisomers, tautomers, solvates, isotope substitutes, polymorphic substances, prodrugs or metabolites thereof, and in the formula, ring A, ring B and R2 are as described in the specification. The invention also provides pharmaceutical compositions containing the compounds, and applications of the compounds in preparation of drugs for treating or preventing NMDA receptor mediated diseases.

Enantioselective Protonation of Silyl Enol Ethers Catalyzed by a Chiral Pentacarboxycyclopentadiene-Based Bronsted Acid

The enantioselective protonation of silyl enol ethers was realized in the presence of a pentacarboxycyclopenta-1,3-diene-based chiral Bronsted acid catalyst with water as an achiral proton source to give the corresponding α-aryl ketones in good yields and up to 75percent ee.

Aromatic compound, preparation method and use of aromatic compound

The invention relates to an aromatic compound, a preparation method and use of the aromatic compound, andspecifically discloses a compound represented by the following formula (I), or a tautomer or anenantiomer or a diastereomer or a racemate of the compound or a mixture of the compound or a pharmaceutically acceptable salt of the compound. The invention further discloses a preparation method ofthe compound and application of the compound in treating nervous systemdiseases.